Skip to main content

Center for Breakthrough Medicines

Page 1

UNITE

DEVELOP

Your Trusted Partner for the Next Generation of Advanced Therapies

MANUFACTURE

BREAKTHROUGH

THE CBM DIFFERENCE

Capacity at Scale

Center for Breakthrough Medicines (CBM) is an advanced therapy

We offer turnkey expansion with modularly-designed and BLA-ready suites for high throughput and maximum yield.

patients that need them. Our end-to-end capabilities include plasmid

Single-Site CDMO

focused CDMO dedicated to delivering life-changing treatments to the DNA, viral vector manufacturing, and cell therapy production from

pre-clinical to commercial scale, with drug substance, drug product, and

analytical services all at a single site. Our team leaders were involved in

commercializing the first cell & gene therapies at leading biopharmas and CDMO’s, and are ready to help guide your innovations from concept to clinic to commercial.

Our capabilities are co-located on a single campus for seamless hand- off between development, manufacturing, and testing.

Expert Team & Partners Our leaders, hailing from top-tier CDMO’s and biopharmas, were involved with bringing the first cell and gene therapies to market, and our academic partners are pioneers in the field.

CAPABILITIES & CAPACITY AT A SINGLE-SITE

Flexible Ways of Working Viral Vector Suites

Cell Therapy Suites

Analytical Assays

We are willing to put skin in the game with flexible terms and milestone-based arrangements.

Integrated Analytical Capabilities THE ONLY FULLY INTEGRATED, END-TO-END PLATFORM

Cutting-edge analytical infrastructure and techniques enable us to rapidly get the critical answers around safety, efficacy, and potency.

FOR ADVANCED THERAPIES R&D

Process Development

Viral Vectors

Plasmid DNA

Cell Therapy

Cell Banking

Analytical Testing

Quality & Regulatory

Customizable Solutions www.breakthroughmedicines.com

Purpose-Built GMP Manufacturing Clinical and commercial GMP manufacturing with end-to-end capabilities from process development through drug substance manufacturing and drug product filling are supported with full testing capabilities.


UNITE

DEVELOP

MANUFACTURE

Process Development

BREAKTHROUGH

Viral Vectors

FULLY INTEGRATED, END-TO-END PLATFORM FOR

FULLY INTEGRATED CAPABILITIES

Plasmid DNA

ADVANCED THERAPIES

Analytical Testing

Research & Development

Cell Therapy

Quality & Regulatory

We provide an innovator company approach to vector and

process design. Our experts assess manufacturability early on

and mitigate risk during development to support the successful and rapid scale-up of high-quality advanced therapies.

Process Development Our experienced team will work side-by-side with yours to optimize upstream and downstream processes for cGMP

Cell Therapy Manufacturing

therapies. We support development through plasmid vector

workflows support autologous products with sophisticated

manufacture of viral vectors and autologous or allogeneic cell

In over 20 cell therapy suites, our flexible equipment and

selection, cell line selection, cell banking, formulation and drug

scheduling and supply chain management, and allogeneic

product development, and process optimization.

products scaled up in adherent and suspension systems.

Plasmid DNA Manufacturing

Cell Banking

Our production capabilities include plasmid DNA and other

CBM offers clients the capability to manufacture cGMP

therapeutics. We have full resources available to support cell

Viral Banks (MVB), and Working Viral Banks (WVB). Integrating

nucleic acids that form the genetic foundation for many

Master Cell Banks (MCB), Working Cell Banks (WCB), Master

and gene therapy programs and rapidly progress them from

this process, including characterization and release services,

R&D to cGMP production.

ensures the safety and longevity of the crucial cell line.

Analytical Development & Testing

Viral Vector Manufacturing

Our Analytical Development and Testing capabilities occupy

With one of the world’s largest single-site viral vector facilities,

efficiently located to be seamlessly integrated with production.

production of Adenovirus, AAV, Lentivirus, and other viral- based

200,000 square feet of lab space on our campus, and are

We provide method development, method transfer, qualification and validation to ensure quality, potency and safety.

Center for Breakthrough Medicines

we have over 20 cGMP suites modularly designed for scalable therapeutics. Clients also have the option to utilize a proven platform licensed from the lab that pioneered gene therapy.

Email: info@cfbm.com www.breakthroughmedicines.com

411 Swedeland Road King of Prussia, PA 19406


Turn static files into dynamic content formats.

Create a flipbook
Center for Breakthrough Medicines by PhilaPACT - Issuu